Related Experiment Videos
Radiofrequency ablation in metastatic disease
1Department of Diagnostic Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany. lubienski@med.uni-heidelberg.de
Summary
Radiofrequency ablation (RFA) offers a curative treatment for selected patients with colorectal cancer liver metastases, especially those ineligible for surgery. This minimally invasive option provides an alternative to surgical resection for secondary liver tumors.
Area of Science:
- Hepatobiliary surgery
- Interventional radiology
- Colorectal cancer oncology
Background:
- Liver metastases are the most frequent site of colorectal cancer spread.
- Hepatic metastases significantly contribute to patient morbidity and mortality.
- Surgical resection offers the best cure potential but is feasible for only 5%-20% of patients.
Purpose of the Study:
- To discuss percutaneous radiofrequency ablation (RFA) as a curative treatment for liver metastases from colorectal cancer.
- To outline technical aspects and patient selection criteria for RFA.
- To review follow-up imaging and outcomes of RFA in this patient population.
Main Methods:
- Image-guided percutaneous radiofrequency ablation (RFA).
- Selection of patients not eligible for surgical resection.
- Discussion of technical considerations and follow-up protocols.
Main Results:
- RFA serves as a curative treatment option for selected patients with liver metastases from colorectal cancer.
- It is particularly valuable for patients unsuitable for surgery.
- The study discusses the technical feasibility, selection criteria, and outcomes.
Conclusions:
- Percutaneous radiofrequency ablation is an effective alternative curative treatment for select patients with colorectal cancer liver metastases.
- Careful patient selection and adherence to technical guidelines are crucial for successful outcomes.
- RFA expands treatment options for patients with secondary liver tumors.